Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biogen
Pharma
Eisai and Biogen's Alzheimer's med Leqembi approved in Europe
The drug has hit several roadblocks in its European regulatory journey after its first rejection last July.
Zoey Becker
Apr 16, 2025 7:52am
Biogen blueprints headquarters move to new digs in Cambridge
Mar 24, 2025 10:15am
NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai
Mar 6, 2025 10:47am
CHMP again backs Leqembi amid flurry of approval recommendations
Feb 28, 2025 10:30am
Roche picks up FDA nod for easier Evrysdi dosing format in SMA
Feb 12, 2025 2:30pm
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
